NEXT-ChemX Corporation posted a net loss of $2,282,812 for 2024, down $228,201 from 2023. The company ended December 31 with $220,911 in current assets, a $4,334,788 Working Capital Deficit and an accumulated stockholders’ deficit of $8,794,922, key constraints for investors.
Key Highlights
- Operating expenses rose 0.2% to $2,131,101 in 2024 from $2,126,383.
- Current Assets stood at $220,911 against a working capital deficit of $4,334,788.
- NEXT-ChemX identifies pandemics, Indian operations and conflict involving China and Pakistan as risks.
NEXT-ChemX Corporation recorded a net loss of $2,282,812 for 2024, down $228,201 from 2023. Revenue was $0 in both periods. At December 31, 2024, the company reported $220,911 in current assets, a working capital deficit of $4,334,788 and an accumulated stockholders’ deficit of $8,794,922.
$2,282,812 Annual Loss
Operating expenses reached $2,131,101 in 2024, up $4,718, or 0.2%, from $2,126,383 in 2023. The company said the lower net loss reflected a $232,919 reduction in other non-operating expenses, which offset the increase in operating costs. NEXT-ChemX operates as one reportable segment, with executive management reviewing financial information on a consolidated basis.
Reported Expense Changes
A receivable write-off of $437,597 was included among the year’s expense items. NEXT-ChemX also said changes involving a senior employee reduced its salary burden by $313,155, while intellectual-property expenses declined by $121,169. The cost actions included shifting development work from a U.S.-based laboratory to Indian subcontractors, ending the laboratory rental and reducing travel, overhead and incidental spending. The company also closed offices, used remote work arrangements and subcontracted engineering work as it sought to contain operating expenses.
Liquidity and Capital Resources
The company reported a working capital deficit of $4,334,788 and an accumulated stockholders’ deficit of $8,794,922 at December 31, 2024. Total current assets were $220,911. NEXT-ChemX is commercializing its Ion-Targeting Continuous-Flow Direct Extraction Technology, and its first controlled pilot system and initial production model for related units will be in India.
India And Pandemic Risks
NEXT-ChemX identifies COVID-19 and future pandemics as risks to Business operations, vendors and customers. Potential effects described by the company include Facility closures, travel restrictions, employee illness, labor instability and reduced Demand for services, all of which could affect commercialization, Liquidity and operating results. The filing says operations in India involve local business conditions, infrastructure limits, bureaucratic delays, security issues and the need for local partnerships for pilot-plant design, construction and development work. The company also cites heightened geopolitical risk involving possible conflict or military confrontation with China and Pakistan. Cybersecurity is managed with an outsourced information-technology security group, while third-party consultants may assist with incident response. NEXT-ChemX said there were no known reported cybersecurity incidents during calendar year 2025 that materially affected its operations or financial results.



Please wait processing your request...